CNTB Latest Press Releases

-- September 30, 2026 --

3 Biotech Stocks Throwing Their Weight Around, and Another that Wants to Help You Lose Yours Globe Newswire 10:22 AM

Connect Biopharma Announces Positive Preliminary Topline Data from its Global Phase 2 Study of Rademikibart as an Add-on Treatment for Acute Exacerbations in Adults with COPD and Type 2 Inflammation Globe Newswire 7:00 AM

-- September 15, 2026 --

Connect Biopharma Announces Positive Preliminary Topline Data from its Global Phase 2 Study of Rademikibart as an Add-on Treatment for Acute Exacerbations in Adult and Adolescent Participants with Asthma and Type 2 Inflammation Globe Newswire 7:00 AM

-- September 3, 2026 --

Connect Biopharma to Present at the H.C. Wainwright 28th Annual Global Investment Conference Globe Newswire 4:05 PM

-- August 12, 2026 --

Connect Biopharma Reports Second Quarter 2026 Financial Results and Provides Business Update Globe Newswire 4:05 PM

-- June 17, 2026 --

Connect Biopharma Announces Completion of Enrollment of Phase 2 Seabreeze STAT Asthma Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in Asthma Globe Newswire 9:00 AM

Market Data Delayed 15 Minutes